These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 31307919)

  • 1. Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability.
    Shoeibi A; Litvan I; Tolosa E; Ser TD; Lee E;
    Parkinsonism Relat Disord; 2019 Sep; 66():87-93. PubMed ID: 31307919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Fully Automated, Atlas-Based Approach for Superior Cerebellar Peduncle Evaluation in Progressive Supranuclear Palsy Phenotypes.
    Nicoletti G; Caligiuri ME; Cherubini A; Morelli M; Novellino F; Arabia G; Salsone M; Quattrone A
    AJNR Am J Neuroradiol; 2017 Mar; 38(3):523-530. PubMed ID: 28034996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic Resonance Parkinsonism Index for evaluating disease progression rate in progressive supranuclear palsy: A longitudinal 2-year study.
    Quattrone A; Morelli M; Quattrone A; Vescio B; Nigro S; Arabia G; Nisticò R; Novellino F; Salsone M; Arcuri P; Luca A; Mazzuca A; Alessio C; Rocca F; Caracciolo M
    Parkinsonism Relat Disord; 2020 Mar; 72():1-6. PubMed ID: 32036297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
    Sakae N; Josephs KA; Litvan I; Murray ME; Duara R; Uitti RJ; Wszolek ZK; Graff-Radford NR; Dickson DW
    Mov Disord; 2019 Nov; 34(11):1655-1662. PubMed ID: 31433871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
    Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy.
    Pilotto A; Gazzina S; Benussi A; Manes M; Dell'Era V; Cristillo V; Cosseddu M; Turrone R; Alberici A; Padovani A; Borroni B
    Neurodegener Dis; 2017; 17(6):286-291. PubMed ID: 28881351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants.
    Lopez G; Bayulkem K; Hallett M
    Acta Neurol Scand; 2016 Oct; 134(4):242-9. PubMed ID: 27070344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?
    Shoeibi A; Litvan I; Juncos JL; Bordelon Y; Riley D; Standaert D; Reich SG; Shprecher D; Hall D; Marras C; Kluger B; Olfati N; Jankovic J
    Parkinsonism Relat Disord; 2019 Dec; 69():34-39. PubMed ID: 31665686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive Supranuclear Palsy: an Update.
    Armstrong MJ
    Curr Neurol Neurosci Rep; 2018 Feb; 18(3):12. PubMed ID: 29455271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and Guadeloupean parkinsonism.
    Steele JC; Caparros-Lefebvre D; Lees AJ; Sacks OW
    Parkinsonism Relat Disord; 2002 Oct; 9(1):39-54. PubMed ID: 12217621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protracted course progressive supranuclear palsy.
    Couto B; Martinez-Valbuena I; Lee S; Alfradique-Dunham I; Perrin RJ; Perlmutter JS; Cruchaga C; Kim A; Visanji N; Sato C; Rogaeva E; Lang AE; Kovacs GG
    Eur J Neurol; 2022 Aug; 29(8):2220-2231. PubMed ID: 35384155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants.
    Street D; Malpetti M; Rittman T; Ghosh BCP; Murley AG; Coyle-Gilchrist I; Passamonti L; Rowe JB
    Brain Commun; 2021; 3(3):fcab206. PubMed ID: 34541533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.
    Litvan I; Agid Y; Calne D; Campbell G; Dubois B; Duvoisin RC; Goetz CG; Golbe LI; Grafman J; Growdon JH; Hallett M; Jankovic J; Quinn NP; Tolosa E; Zee DS
    Neurology; 1996 Jul; 47(1):1-9. PubMed ID: 8710059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial aggregation of parkinsonism in progressive supranuclear palsy.
    Donker Kaat L; Boon AJ; Azmani A; Kamphorst W; Breteler MM; Anar B; Heutink P; van Swieten JC
    Neurology; 2009 Jul; 73(2):98-105. PubMed ID: 19458322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials.
    Street D; Jabbari E; Costantini A; Jones PS; Holland N; Rittman T; Jensen MT; Chelban V; Goh YY; Guo T; Heslegrave AJ; Roncaroli F; Klein JC; Ansorge O; Allinson KSJ; Jaunmuktane Z; Revesz T; Warner TT; Lees AJ; Zetterberg H; Russell LL; Bocchetta M; Rohrer JD; Burn DJ; Pavese N; Gerhard A; Kobylecki C; Leigh PN; Church A; Hu MTM; Houlden H; Morris H; Rowe JB
    Brain; 2023 Aug; 146(8):3232-3242. PubMed ID: 36975168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vestibular symptoms as the presenting feature of progressive supranuclear palsy.
    Haggstrom L; Brew B; Sutton I; Tisch S
    J Clin Neurosci; 2018 Apr; 50():74-76. PubMed ID: 29398194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal structural connectivity in progressive supranuclear palsy-Richardson syndrome.
    Prasad S; Rajan A; Pasha SA; Mangalore S; Saini J; Ingalhalikar M; Pal PK
    Acta Neurol Scand; 2021 Apr; 143(4):430-440. PubMed ID: 33175396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy.
    Pagonabarraga J; Horta-Barba A; Busteed L; Bejr-Kasem H; Illán-Gala I; Aracil-Bolaños I; Marín-Lahoz J; Pascual-Sedano B; Pérez J; Campolongo A; Izquierdo C; Martinez-Horta S; Sampedro F; Kulisevsky J
    Parkinsonism Relat Disord; 2021 Apr; 85():63-68. PubMed ID: 33744691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
    Picillo M; Cuoco S; Tepedino MF; Cappiello A; Volpe G; Erro R; Santangelo G; Pellecchia MT; Barone P;
    J Neurol; 2019 Jul; 266(7):1727-1735. PubMed ID: 30989369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
    Litvan I; Campbell G; Mangone CA; Verny M; McKee A; Chaudhuri KR; Jellinger K; Pearce RK; D'Olhaberriague L
    Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.